SBL Cicuta Maculata 1000CH (30ml)
Original price was: ₹140.00.₹125.00Current price is: ₹125.00.
SBL Cicuta Maculata 1000CH Indications:
SBL Cicuta Maculata Dilution is a homoeopathic remedy which is useful in treating disorders related to the nervous system. Formulated with the Cicuta maculata, it is effective in treating epilepsy. Stomach related disorders such as constipation, pain and nausea can also be relieved by its use. It is effective in treating fever which is accompanied with profuse sweating all over the body.
Directions For Use:
Dosage should be directed by the physician. It can be taken along with other allopathic medicines.
In stock
For Convulsions, jerking, scalp eczema, swollen mammary gland, Tremors
Brand
SBL
You must be logged in to post a review.
Related Products
In stock
SBL Phosphorus 200 (30ml) – Liquid Dilution in 200 CH Potency.
In stock
In stock
Dr. Reckeweg Gelsemium 200CH
Take 5 drops in half cup of water three times a day.
You can also medicate the globules and take 3 times a day or as prescribed by the physician.
We recommend you to take under physicians guidance.
In stock
In stock
Sleepiness, difficult speech, eye complaints, headache
In stock
In stock
SBL Berberis Vulgaris 30CH
Dosage: As recommended 10 drops in 1/4th cup of water should be taken 3 times a day.
Or as directed.
In stock
In stock
SBL Pulsatilla Nigricans 30
In stock
In stock
Delirium, Hallucinations, Nervous excitement, Sleeplessness, Fits
In stock
In stock
SBL Gelsemium Sempervirens 200
In stock
In stock
Constipation, Cough, Dyspepsia, Eructations, Hemorrhages, Malaria
In stock
In stock
Dr. Reckeweg Gelsemium 1000CH
Take 5 drops in half cup of water three times a day.
You can also medicate the globules and take 3 times a day or as prescribed by the physician.
We recommend you to take under physicians guidance.
In stock
In stock
Boils, Fits, Gout, Piles, Indigestion, Nose-bleed, Worms, Joint Pain.
In stock
In stock
SBL Acid Phosphoricum 30
In stock
In stock
SBL Calcarea Phosphoricum 30
In stock
Reviews
There are no reviews yet.